Annual Current Assets
$20.73 B
+$5.16 B+33.14%
31 December 2023
Summary:
Novo Nordisk A/S annual total current assets is currently $20.73 billion, with the most recent change of +$5.16 billion (+33.14%) on 31 December 2023. During the last 3 years, it has risen by +$9.86 billion (+90.61%). NVO annual current assets is now at all-time high.NVO Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$29.23 B
+$3.75 B+14.72%
30 September 2024
Summary:
Novo Nordisk A/S quarterly total current assets is currently $29.23 billion, with the most recent change of +$3.75 billion (+14.72%) on 30 September 2024. Over the past year, it has increased by +$9.09 billion (+45.14%). NVO quarterly current assets is now at all-time high.NVO Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.1% | +45.1% |
| 3 y3 years | +90.6% | +105.4% |
| 5 y5 years | +129.1% | +214.6% |
NVO Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +90.6% | at high | +125.1% |
| 5 y | 5 years | at high | +129.1% | at high | +214.6% |
| alltime | all time | at high | +5313.0% | at high | +7531.6% |
Novo Nordisk A/S Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.23 B(+14.7%) |
| June 2024 | - | $25.48 B(+51.3%) |
| Mar 2024 | - | $16.84 B(-18.8%) |
| Dec 2023 | $25.96 B(+35.5%) | $20.73 B(+2.9%) |
| Sept 2023 | - | $20.14 B(+0.3%) |
| June 2023 | - | $20.07 B(+20.3%) |
| Mar 2023 | - | $16.68 B(+7.1%) |
| Dec 2022 | $19.15 B(+15.5%) | $15.57 B(-1.4%) |
| Sept 2022 | - | $15.79 B(+9.2%) |
| June 2022 | - | $14.46 B(+11.3%) |
| Mar 2022 | - | $12.99 B(-0.3%) |
| Dec 2021 | $16.58 B(+26.8%) | $13.03 B(-8.4%) |
| Sept 2021 | - | $14.23 B(+15.3%) |
| June 2021 | - | $12.35 B(+27.6%) |
| Mar 2021 | - | $9.68 B(-11.0%) |
| Dec 2020 | $13.08 B(+38.1%) | $10.88 B(-6.4%) |
| Sept 2020 | - | $11.62 B(+4.6%) |
| June 2020 | - | $11.10 B(+18.9%) |
| Mar 2020 | - | $9.33 B(-0.3%) |
| Dec 2019 | $9.47 B(+19.5%) | $9.36 B(+0.8%) |
| Sept 2019 | - | $9.29 B(+3.9%) |
| June 2019 | - | $8.95 B(+12.9%) |
| Mar 2019 | - | $7.92 B(-12.4%) |
| Dec 2018 | $7.92 B(+16.3%) | $9.05 B(+7.4%) |
| Sept 2018 | - | $8.42 B(-5.6%) |
| June 2018 | - | $8.92 B(+8.1%) |
| Mar 2018 | - | $8.25 B(-14.8%) |
| Dec 2017 | $6.81 B(+26.8%) | $9.68 B(+7.1%) |
| Sept 2017 | - | $9.04 B(-0.4%) |
| June 2017 | - | $9.07 B(+13.5%) |
| Mar 2017 | - | $7.99 B(-5.9%) |
| Dec 2016 | $5.37 B(+0.0%) | $8.50 B(+9.5%) |
| Sept 2016 | - | $7.76 B(-1.4%) |
| June 2016 | - | $7.87 B(+11.6%) |
| Mar 2016 | - | $7.05 B(-12.7%) |
| Dec 2015 | $5.37 B(+6.9%) | $8.08 B(+4.0%) |
| Sept 2015 | - | $7.77 B(+9.1%) |
| June 2015 | - | $7.12 B(+12.9%) |
| Mar 2015 | - | $6.30 B(-16.6%) |
| Dec 2014 | $5.02 B(-4.0%) | $7.56 B(+7.7%) |
| Sept 2014 | - | $7.02 B(+12.1%) |
| June 2014 | - | $6.26 B(-1.5%) |
| Mar 2014 | - | $6.35 B(-18.4%) |
| Dec 2013 | $5.23 B(+15.8%) | $7.78 B(+5.2%) |
| Sept 2013 | - | $7.40 B(+16.0%) |
| June 2013 | - | $6.38 B(+3.7%) |
| Mar 2013 | - | $6.15 B(-13.6%) |
| Dec 2012 | $4.52 B(+3.3%) | $7.12 B(+0.5%) |
| Sept 2012 | - | $7.08 B(+17.8%) |
| June 2012 | - | $6.01 B(-7.6%) |
| Mar 2012 | - | $6.51 B(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $4.38 B(+1.7%) | $6.90 B(-2.6%) |
| Sept 2011 | - | $7.08 B(-3.7%) |
| June 2011 | - | $7.35 B(+9.5%) |
| Mar 2011 | - | $6.71 B(+0.9%) |
| Dec 2010 | $4.30 B(+1.3%) | $6.65 B(+7.3%) |
| Sept 2010 | - | $6.20 B(+11.8%) |
| June 2010 | - | $5.54 B(-2.6%) |
| Mar 2010 | - | $5.69 B(-9.4%) |
| Dec 2009 | $4.25 B(+4.8%) | $6.28 B(+3.0%) |
| Sept 2009 | - | $6.10 B(+8.9%) |
| June 2009 | - | $5.60 B(+10.0%) |
| Mar 2009 | - | $5.10 B(-6.8%) |
| Dec 2008 | $4.05 B(-11.7%) | $5.47 B(+6.7%) |
| Sept 2008 | - | $5.12 B(-7.5%) |
| June 2008 | - | $5.54 B(+6.0%) |
| Mar 2008 | - | $5.22 B(+9.8%) |
| Dec 2007 | $4.59 B(+8.7%) | $4.76 B(+6.9%) |
| Sept 2007 | - | $4.45 B(+6.7%) |
| June 2007 | - | $4.17 B(+11.2%) |
| Mar 2007 | - | $3.75 B(+1.7%) |
| Dec 2006 | $4.22 B(+18.9%) | $3.69 B(+5.6%) |
| Sept 2006 | - | $3.49 B(+0.3%) |
| June 2006 | - | $3.48 B(+13.6%) |
| Mar 2006 | - | $3.06 B(-1.2%) |
| Dec 2005 | $3.55 B(-1.7%) | $3.10 B(+5.9%) |
| Sept 2005 | - | $2.93 B(+7.8%) |
| June 2005 | - | $2.71 B(-4.6%) |
| Mar 2005 | - | $2.84 B(-12.6%) |
| Dec 2004 | $3.61 B(+17.3%) | $3.25 B(+17.8%) |
| Sept 2004 | - | $2.76 B(+8.3%) |
| June 2004 | - | $2.55 B(+1.5%) |
| Mar 2004 | - | $2.51 B(-8.9%) |
| Dec 2003 | $3.08 B(+23.1%) | $2.76 B(+42.0%) |
| Dec 2002 | $2.50 B(+40.5%) | $1.94 B(+18.5%) |
| Dec 2001 | $1.78 B(+18.2%) | $1.64 B(+4.9%) |
| Dec 2000 | $1.50 B(+5.3%) | $1.56 B(-7.5%) |
| Dec 1999 | $1.43 B(-36.1%) | $1.69 B(-17.4%) |
| Dec 1998 | $2.24 B(+18.7%) | $2.05 B(+8.6%) |
| Dec 1997 | $1.88 B(-0.9%) | $1.88 B(+1.9%) |
| Dec 1996 | $1.90 B(+0.4%) | $1.85 B(+6.5%) |
| Dec 1995 | $1.89 B(+45.3%) | $1.74 B(-20.0%) |
| Dec 1994 | $1.30 B(-12.1%) | $2.17 B(+59.7%) |
| Dec 1993 | $1.48 B(+49.7%) | $1.36 B(-19.6%) |
| Dec 1992 | $990.68 M(-13.7%) | $1.69 B(+17.8%) |
| Dec 1991 | $1.15 B(+13.2%) | $1.44 B(+25.0%) |
| Dec 1990 | $1.01 B(+27.3%) | $1.15 B(+18.8%) |
| Dec 1989 | $796.27 M(+26.4%) | $966.37 M(+36.0%) |
| Dec 1988 | $629.89 M(-5.7%) | $710.80 M(+3.5%) |
| Dec 1987 | $667.63 M(+29.1%) | $687.01 M(+16.1%) |
| Dec 1986 | $517.16 M(+51.0%) | $591.69 M(+23.7%) |
| Dec 1985 | $342.58 M(+45.0%) | $478.19 M(+24.8%) |
| Dec 1984 | $236.30 M | $383.03 M |
FAQ
- What is Novo Nordisk A/S annual total current assets?
- What is the all time high annual current assets for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual current assets year-on-year change?
- What is Novo Nordisk A/S quarterly total current assets?
- What is the all time high quarterly current assets for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly current assets year-on-year change?
What is Novo Nordisk A/S annual total current assets?
The current annual current assets of NVO is $20.73 B
What is the all time high annual current assets for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total current assets is $20.73 B
What is Novo Nordisk A/S annual current assets year-on-year change?
Over the past year, NVO annual total current assets has changed by +$5.16 B (+33.14%)
What is Novo Nordisk A/S quarterly total current assets?
The current quarterly current assets of NVO is $29.23 B
What is the all time high quarterly current assets for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total current assets is $29.23 B
What is Novo Nordisk A/S quarterly current assets year-on-year change?
Over the past year, NVO quarterly total current assets has changed by +$9.09 B (+45.14%)